Compare ALLO & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | FDBC |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 253.8M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | FDBC |
|---|---|---|
| Price | $1.48 | $43.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $8.27 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 7.1K |
| Earning Date | 03-12-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 3.90% |
| EPS Growth | N/A | ★ 68.46 |
| EPS | N/A | ★ 4.51 |
| Revenue | N/A | ★ $88,597,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.78 |
| Revenue Growth | N/A | ★ 24.36 |
| 52 Week Low | $0.86 | $37.00 |
| 52 Week High | $3.78 | $50.00 |
| Indicator | ALLO | FDBC |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 47.49 |
| Support Level | $1.54 | $43.01 |
| Resistance Level | $1.83 | $45.97 |
| Average True Range (ATR) | 0.13 | 1.17 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 25.23 | 55.33 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.